Candel Therapeutics Inc
NASDAQ:CADL
Candel Therapeutics Inc
NASDAQ:CADL
Price:
4.985
USD
-0.7%
Market Cap:
$365.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Candel Therapeutics Inc
NASDAQ:CADL
|
US |
|
Deutsche Lufthansa AG
XETRA:LHA
|
DE |
|
Tokio Marine Holdings Inc
TSE:8766
|
JP |
|
M
|
Mars Group Holdings Corp
TSE:6419
|
JP |
|
Harmonic Drive Systems Inc
TSE:6324
|
JP |
|
Grendene SA
BOVESPA:GRND3
|
BR |
|
DocCheck AG
XETRA:AJ91
|
DE |
|
Shree Rama Newsprint Ltd
NSE:RAMANEWS
|
IN |
|
I
|
ISMT Ltd
NSE:ISMTLTD
|
IN |
|
Dhampur Sugar Mills Ltd
NSE:DHAMPURSUG
|
IN |
|
T
|
Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075
|
CN |
|
V
|
V L Enterprise PCL
SET:VL
|
TH |
Multiples-Based Value
The
Multiples-Based Value for
Candel Therapeutics Inc (CADL)
under the Base Case is
hidden
USD.
Compared with the current market price of 4.985 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CADL Multiples-Based Value
LOCKED
Multiples Across Competitors
CADL Competitors Multiples
Candel Therapeutics Inc Competitors
Candel Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Candel Therapeutics Inc
NASDAQ:CADL
|
367.7m USD | 0 | -9.6 | -6.2 | -6.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD | 5 | 23.8 | 13.9 | 13.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD | 5.9 | 20.3 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD | 9.1 | 27.7 | 20.7 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD | 5.6 | 17.8 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3 | 33.2 | 11.2 | 14 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.4 | 40.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
